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Abstract
Background: Pulmonary vascular medial hypertrophy in hypoxic pulmonary arterial hypertension (PAH) is caused in part by
decreased apoptosis in pulmonary artery smooth muscle cells (PASMCs). Puerarin, an isoflavone purified from the Chinese
medicinal herb kudzu, ameliorates chronic hypoxic PAH in animal models. Here we investigated the effects of puerarin on
apoptosis of hypoxic human PASMCs (HPASMCs), and to determine the possible underlying mechanisms.
Methodology/Principal Findings: HPASMCs were cultured for 24 h in normoxia or hypoxia (5% O2) conditions with and
without puerarin. Cell number and viability were determined with a hemacytometer or a cell counting kit. Apoptosis was
detected with a TUNEL test, rhodamine-123 (R-123) fluorescence, a colorimetric assay, western blots, immunohistochemical
staining and RT-PCR. Hypoxia inhibited mitochondria-dependent apoptosis and promoted HPASMC growth. In contrast,
after puerarin (50 mM or more) intervention, cell growth was inhibited and apoptosis was observed. Puerarin-induced
apoptosis in hypoxic HPASMCs was accompanied by reduced mitochondrial membrane potential, cytochrome c release
from the mitochondria, caspase-9 activation, and Bcl-2 down-regulation with concurrent Bax up-regulation.
Conclusions/Significance: Puerarin promoted apoptosis in hypoxic HPASMCs by acting on the mitochondria-dependent
pathway. These results suggest a new mechanism of puerarin relevant to the management of clinical hypoxic pulmonary
hypertension.
Citation: Chen C, Chen C, Wang Z, Wang L, Yang L, et al. (2012) Puerarin Induces Mitochondria-Dependent Apoptosis in Hypoxic Human Pulmonary Arterial
Smooth Muscle Cells. PLoS ONE 7(3): e34181. doi:10.1371/journal.pone.0034181
Editor: Rory Edward Morty, University of Giessen Lung Center, Germany
Received December 9, 2010; Accepted February 28, 2012; Published March 23, 2012
Copyright:  2012 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by National Natural Science Foundation of China (No. 30670933). The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: wzyxywlx@163.com
Introduction
Pulmonary vascular remodeling, the pathological basis of
pulmonary arterial hypertension (PAH), is characterized by
changes in pulmonary vascular structure associated with medial
hypertrophy, which is due partly to the inhibition of pulmonary
artery smooth muscle cell (PASMC) apoptosis [1–4]. Induction of
PASMC apoptosis results in progressive regression of pulmonary
vascular medial hypertrophy [5–9]. The role of mitochondria in
pulmonary vascular biology, and PAH specifically, has generated
substantial interest in recent years. Hypoxia, a common
pathophysiologic state, is one of the most important pathological
factors that induces pulmonary hypertension (PH), and has a
mitogenic effect on PASMCs in vitro [10,11].
Mitochondria-dependent apoptosis has been identified as a
potential target for PAH [7]. The mitochondrial apoptotic pathway
is mediated by Bcl-2 family proteins, which have a central
regulatory role in deciding the fate of cells through interactions
between pro- and anti-apoptotic members [12]. The breakdown of
the mitochondrial membrane potential (Dym) is an earlystage of the
apoptotic process, and precedes nuclear disintegration [13]. Dym
disruption is mediated by the opening of permeability transition
(PT) pores in the inner mitochondrial membrane, leading to matrix
swelling, outer membrane rupture, and the release of apoptotic
signaling molecules, such as cytochrome c, from the intermembrane
space [14,15,16]. An increase in cytosolic cytochrome c, in
association with Apaf-1, is a trigger for the activation of caspase-9,
which then activates cysteine proteases (e.g., caspases-3, -5, and -7)
that are central executioners of the apoptotic pathway [17].
Mitochondria-dependent apoptosis was suppressed in hypoxia-
induced human PASMCs (HPASMCs) in vitro [18] and in PASMCs
from patients and rats with PAH [8].
Puerarin [7-hydroxy-3-(4-hydroxyphenyl)-1-benzopyran-4-one
8-(b-D-glucopyranoside); C21H20C9], the major active ingredient
extracted from the Chinese medicinal herb kudzu, has multiple
pharmacological activities [19]. It has long been used to treat
angiocardiopathy, including coronary artery diseases (CAD) [20]
and hypertension [21]. Additionally, puerarin induces apoptosis in
HT-29 colon cancer cells [22] and breast cancer cells [23]. Recent
findings [24] suggest that puerarin can improve pulmonary vascular
remodeling in rats with PH, but the underlying mechanisms,
especially the effect on the growth of HPASMCs, remain unclear.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34181In this study, we investigated HPASMC apoptosis in hypoxic
conditions, and puerarin-induced apoptosis in hypoxic HPASMCs.
Materials and Methods
Materials
HPASMCs and a Smooth Muscle Cell Growth Medium-2
(SmGM-2) kit were purchased from PromoCell GmbH (Heidel-
berg, Germany). Injectable puerarin was purchased from Zhengz-
hou Lingrui Pharmaceutical Co., Ltd. (Henan, China). Trypan
blue and rhodamine-123 (R-123) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). An In-Situ Cell Death Detection
Kit was purchased from Roche Diagnostics (Penzberg, Germany).
A Cell Counting Kit-8 (CCK-8) was from Dojindo Laboratories
(Kumamoto, Japan). A Cytochrome c Releasing Apoptosis Assay
Kit and Caspase-9 Colorimetric Assay Kit were purchased from
Biovision (Mountain View, CA, USA). A mouse anti-a-actin
monoclonal antibody, rabbit anti-Bcl-2 and anti-Bax polyclonal
antibody were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). A mouse anti-cytochrome oxidase IV (COXIV)
monoclonal antibody was purchased from Abcam (Cambridge,
UK). Horseradish peroxidase (HRP) -conjugated monoclonal
mouse anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was purchased from Kangchen Bio-tech (Shanghai, China).
Peroxidase-labeled affinity purified antibody to mouse IgG
(H+L) was purchased from KPL (Gaithersburg, MD, USA). Alexa
fluor 488-labeled goat anti-mouse IgG (H+L) was purchased from
Molecular Probes (Eugene, OR, USA). An ImmPRESS reagent
anti-rabbit Ig kit was purchased from Vector Laboratories
(Burlingame, CA, USA). Dulbecco’s modified Eagle’s medium
(DMEM; high glucose), Trizol and SYBR Green were purchased
from Invitrogen (Carlsbad, CA, USA). BeyoECL Plus was
purchased from Beyotime Bio-tech (Jiangsu, China).
Cell culture and treatments
Recovery of cryopreserved HPASMCs was performed according
to supplier instructions. HPASMCs were cultured in SmGM-2
supplemented with 5% fetal bovine serum (FBS), 2 ng/ml basic
fibroblast growth factor, 5 mg/ml insulin, and 0.5 ng/ml epidermal
growth factor(completemedium)maintainedat37uCwith5%CO2.
The medium was changed every two days. After reaching 80 - 90%
confluency, cells were washed with phosphate-buffered saline (PBS;
pH 7.4) and treated with 0.05% trypsin-EDTA for further passage.
Cells were used at passages 4 - 10 for experiments. No changes in
cell morphology were noted and cells were positive for a-smooth
muscle actin by immunofluorescence. For all experiments, cells
were made quiescent by incubation in serum-free DMEM for 24 h.
Hypoxia treatment was performed in a CO2-N2 incubator
(Heraeus, Germany) at 5% O2/5% CO2/90% N2. HPASMCs
were divided into 7 groups: (1) Normal (N), in which cells were
cultured in serum-freeDMEM under normoxia (21% O2,5 %C O 2)
for 24 h; (2) Normoxia + puerarin (NP), in which cells were cultured
in serum-free DMEM with puerarin (50 mM) for 24 h under
normoxia conditions; (3) Hypoxia (H), in which cells were cultured
inserum-freeDMEMunderhypoxia(5%O2,5%CO 2)for24 h;(4)
Hypoxia + 1 mM puerarin (HP1), in which cells were cultured in
serum-free DMEM with puerarin (1 mM) for 24 h under hypoxia;
(5) Hypoxia +10 mM puerarin (HP10); (6) Hypoxia +50 mM
puerarin (HP50); and (7) Hypoxia +100 mM puerarin (HP100).
Determination of cell proliferation
Cell proliferation was quantified by counting the cell number
directly and with CCK-8. Briefly, HPASMCs were seeded in
6-well microplates at 5610
4 cells/ml. Cell number was determined
with a hemacytometer using 0.45% trypan blue. For CCK-8
measurements, cells were plated in flat-bottomed 96-well micro-
plates at 1610
4 cells/well and incubated in complete medium at
37uCin5%CO 2/95%humidityairfor24 h (3wellsineachgroup),
then treated as described above. CCK-8 (10 ml/well) was added to
the wells at the end of the experiment. After incubation at 37uC for
2 h, the absorbance of each well was determined using a microplate
reader (ELX800, BioTek Instruments, Winooski, VT, USA) at
450 nm.
Detection of apoptosis
After treatment, the cells were fixed with 4% paraformaldehyde
in PBS for 1 h at 25uC. Cells were subjected to a terminal
deoxynucleotidyl transferase-mediated deoxyuridine triphosphate
nick end labeling (TUNEL) assay using the In-Situ Cell Death
Detection Kit according to the manufacturer’s instructions.
TUNEL-positive cells were colored using diaminobenzidine
(DAB) as the chromogen, and counterstained with hematoxylin.
The percentage of TUNEL-positive cells was assessed in five
randomly selected fields each section.
Measurement of mitochondrial membrane potential
(Dym)
Cells grown on coverslips (20 mm) were incubated with R-123
(5 mg/ml) for 30 min at 37uC. R-123 was taken up selectively by
mitochondria in a manner dependent on Dym. R-123 fluorescence
was excited at 488 nm and measured at 530 nm with a laser
scanning confocal microscope (Olympus, Tokyo, Japan). In
isolated mitochondria, the relationship between R-123 fluores-
cence and Dym is linear. Disruption of Dym was associated with a
decrease in fluorescence due to a lack of R-123 retention. The
fluorescence intensity of R-123 was analyzed with Image-Pro plus
(v. 6.0) software (Media Cybernetics, Bethesda, MD, USA). Each
group consisted of three cover slips randomly selected for analysis.
Western blotting analysis
Mitochondrial protein and cytosolic protein were isolated using
the Cytochrome c Releasing Apoptosis Assay kit according to the
manufacturer’s instructions. The proteins were quantified by the
Bradford method with bovineserumalbumin(BSA)asthestandard.
Equal amounts of proteins (20 mg) were separated by 12% SDS-
PAGE and transferred onto a polyvinylidene fluoride (PVDF)
membrane (Millipore, Billerica, MA, USA). Blots were blocked in
Tris-buffered saline with Tween 20 (TBST) containing 5% BSA for
2 h. Subsequently, the membrane was incubated overnight at 4uC
with specific primary antibodies: mouse anti-cytochrome c
monoclonal antibody (1 mg/ml) and mouse anti-COXIV monoclo-
nal antibody(0.5 mg/ml). The membranes were washed with TBST
buffer, and then incubated with HRP-labeled anti-mouse Ig
(0.1 mg/ml). Detection of immunoreactive bands were performed
using BeyoECL Plus reagents. After scanning the X-ray film, the
optical densityof the immunoblots was calculatedwiththe Quantity
one 24.6.2software (Bio-Rad Laboratories,Hercules, CA,USA). A
membrane incubated with a HRP-conjugated monoclonal anti-
GAPDH (0.1 ug/ml) served as the control.
Caspase-9 activity assay
Caspase-9 activity was measured through cleavage of the colorless
caspase-9 specific substrate acetyl-Leu-Glu-His-Asp-p-nitroanilide
(Ac-LEHD-pNA) to release the chromophore p-nitroaniline (pNA).
The assay was performed using the Caspase-9 Colorimetric Assay
Kit according to the instructions. Briefly, cells were lysed with chilled
lysis bufferfollowed bycentrifugation for1 minat10,0006g,andthe
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37uC for 2 h. The absorbance of pNA (405 nm) was measured for
each sample on a microplate reader (ELX800, BioTek Instruments,
Winooski, VT, USA).
Immunohistochemical detection of Bcl-2 and Bax
proteins expression
Immunohistochemistry was used to detect the expression of Bcl-2
and Bax proteins using streptavidin-peroxidase (SP). After treat-
ment, cells were fixed with 4% paraformaldehyde in PBS at room
temperature for 20 min. Endogenous peroxidase in the section was
blocked by 3% hydrogen peroxide for 15 min at room temperature.
The sections were blocked in PBS containing 10% normal horse
serum for 30 min at room temperature. The cells were incubated
withthe primary antibody, a rabbit polyclonal antibody against Bcl-
2 or Bax protein (1:100 dilution), at 4uC overnight. After washing
three times with PBS, sections were incubated with ImmPRESS
reagent anti-rabbit Ig for 30 min. They were then washed three
times with PBS. Finally, specimens were incubated in DAB for
Figure 1. HPASMCs morphology and cell growth. A) Typical ‘‘hill and valley’’ appearance of HPASMCs under phase contrast microscope. B)
Immunofluorescent identification of a- smooth muscle actin was positive. C) Effect of hypoxia and puerarin on cell number. HPASMCs were cultured
for 24 h in normoxia or hypoxia (5% O2) with and without puerarin. Cell number was determined with a hemacytometer using 0.45% trypan blue. D)
Cell viability was tested with CCK-8. E) Apoptosis was detected with a TUNEL assay. * P,0.05 vs. the N group; # P,0.05 vs. the H group; n=3.
doi:10.1371/journal.pone.0034181.g001
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entire sections were acquired using a digital camera (Nikon, Tokyo,
Japan), and were analyzed with Image-Plus (v. 6.0). The average
optical density, representing protein expression, was counted in four
random fields (obtained using a 206objective) each cover slip.
Detection of Bcl-2 and Bax mRNA by real-time
quantitative reverse transcription -polymerase chain
reaction (RT-PCR)
Total RNA was isolated from the cells using Trizol reagent
according to the manufacturer’s protocol. RNA concentration and
purityweremeasuredwithaspectrophotometeratA260andA260/
280, respectively. The reverse transcription reaction was performed
with the Gene Amp PCR System 9700 (Applied Biosystems,
Carlsbad, CA, USA) for the first-strand cDNA synthesis. RT-PCR
was performed on a Rotor-Gene 3000 apparatus (Corbett Research
Company, Sydney, Australia) with SYBR Green fluorescent dye.
The sequences of primers used are as follows: Bax, forward: 59-
CCTTTTCTACTTTGCCAGCAAAC-39 and reverse: 59- GAG-
GCCGTCCCAACCAC-39; Bcl-2, forward: 59- ATGTGTGTG-
GAGAGCGTCAACC-39 and reverse: 59- TGAGCAGAGTCTT-
CAGAGACAGCC-39; GAPDH, forward: 59- CTCTCTGCTC-
CTCCTGTTCGAC-39 and reverse: 59- TGAGCGATGTGGCT-
CGGCT-39.The PCRconditionswere asfollows:a pre-denaturing
at 95uC for 5 min, followed by 35 cycles of denaturation at 95uC for
10 s, annealing/extension at 59uC for 15 s, and then 72uC for 20 s.
A relative amount for each gene examined was obtained from a
standard curve generated by plotting the cycle threshold value
against the concentration of a serially diluted RNA sample
expressing the gene of interest. This amount was normalized to
the level of GAPDH mRNA.
Statistical analyses
Data are expressed as the mean 6 the standard deviation (SD)
with the number (n) of experiments. Differences between data sets
were assessed by one-way ANOVA followed by a Student-Newman-
Keuls test. A P,0.05 was considered statistically significant.
Results
The effect of hypoxia and puerarin on the cell growth of
HPASMCs
As shown in Figure 1A and B, confluent HPASMCs manifested
typical ‘‘hill and valley’’ features, and were positive for a-smooth
Figure 2. Hypoxia increased Dym in HPASMCs, an effect reversed by puerarin. Dym was measured with R-123. The H group had increased
Dym compared to the N group, while puerarin restored Dym in hypoxic HPASMCs. * P,0.05 vs. the N group; # P,0.05 vs. the H group; n=3.
doi:10.1371/journal.pone.0034181.g002
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group, cell number was increased in the H group (10.3360.80 vs.
8.6760.58 cells/ml, respectively; Figure 1C). Puerarin significantly
inhibited HPASMC growth stimulated by hypoxia in a dose-
dependent manner. CCK-8 confirmed the effect of hypoxia (H
group; Figure 1D). A significant decrease in cell viability was
observed upon treatment with puerarin ina dose-dependent manner
(50 to 100 mM), however, 50 mM puerarin had no significant effect
on cell number or viability in normoxic HPASMCs.
Hypoxia and puerarin affect HPASMC apoptosis
To determine whether puerarin inhibited cell viability by
inducing apoptosis in hypoxic HPASMCs, a TUNEL assay was
used. As shown in Figure 1E, the percentage of TUNEL-positive
cells decreased in the H group, compared to the N group
(2.3560.73% vs. 4.1360.85%, respectively; P,0.05). In addition,
there were significant increases in TUNEL-positive cells at 50 and
100 mM puerarin after 24 h exposure. Indeed, a 2.93 and 3.76-
fold, respectively, increase in TUNEL-positive cells over the H
group was observed. However, 50 mM puerarin had no significant
effect on apoptosis in normoxic HPASMCs.
Hypoxia and puerarin alter the Dym of HPASMCs
As shown in Figure 2, the H group had increased Dym
compared to the N group. The treatment of hypoxic HPASMCs
with puerarin markedly decreased the Dym in a dose-dependent
manner. Puerarin (50 mM) did not affect Dym in normoxic
HPASMCs.
Figure 3. Puerarin induced cytochrome c release and caspase-9 activation in hypoxic but not normoxic HPASMCs. A) Cytochrome c
distribution. COXIV and GAPDH detection were used to determine the purity of the cytoplasmic fraction and to control for equal protein loading. B)
Caspase-9 activity. * P,0.05 vs. the N group; # P,0.05 vs. the H group; n=3.
doi:10.1371/journal.pone.0034181.g003
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activation
To determine whether mitochondria-dependent apoptosis was
involved, we detected mitochondrial and cytosolic proteins by
western blotting. COXIV, a mitochondrial protein whose
localization does not change on disruption of the mitochondrial
outer membrane, was used to determine the purity of the
cytoplasmic fraction and as a control for equal mitochondrial
protein loading. GAPDH was used as the cytosolic loading control.
As shown in Figure 3A, compared to the N group, leakage of the
caspase activator cytochrome c from the mitochondria to the
cytosol was attenuated in the H group. Puerarin enhanced the
leakage of cytochrome c from the mitochondria in hypoxic
HPASMCs when applied at 10, 50, and 100 mM after 24 h.
However, puerarin did not affect cytochrome c distribution in
normoxic HPASMCs.
Figure 4. Puerarin decreased Bcl-2 expression in hypoxic HPASMCs. Treated HPASMCs were assayed for Bcl-2 protein (A) and mRNA (B).
* P,0.05 vs. the N group; # P,0.05 vs. the H group; n=3.
doi:10.1371/journal.pone.0034181.g004
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e34181Caspase-9 is an initiator caspase in the mitochondrial death
pathway. We measured the enzymatic activity of caspase-9 by an
in vitro colorimetric assay using cell lysates of HPASMCs treated
with hypoxia or puerarin. As shown in Figure 3B, the activity of
caspase-9 was suppressed in the H group compared to the N
group. Puerarin increased caspase-9 activity in hypoxic
HPASMCs in a dose-dependent manner, but had no effect on
caspase-9 activity in normoxic cells.
Puerarin decreased Bcl-2, but increased Bax expression,
in hypoxic HPASMCs
Bcl-2 family member proteins mediate the mitochondrial
apoptotic pathway. Therefore, we examined the effect of hypoxia
and puerarin on Bcl-2 and Bax expression (Figure 4). The
expression of Bcl-2 protein and mRNA significantly increased in
the H group compared to the N group, while puerarin suppressed
Bcl-2 protein and mRNA expression in hypoxic HPASMCs in a
Figure 5. Puerarin increased Bax expression in hypoxic HPASMCs. Treated HPASMCs were assayed for Bax protein (A) and mRNA (B). *
P,0.05 vs. the N group; # P,0.05 vs. the H group; n=3.
doi:10.1371/journal.pone.0034181.g005
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e34181dose-dependent manner. Bax protein and mRNA expression
(Figure 5) had no obvious changes in the H group compared to the
N group. Puerarin (50 mM and 100 mM) induced Bax protein and
mRNA expression in hypoxic HPASMCs. However, puerarin
(50 mM) did not affect Bcl-2 and Bax expression significantly in
normoxic HPASMCs.
Discussion
Precise control of the balance of apoptosis and cell proliferation
in PASMCs is critical in maintaining the normal structural and
functional integrity of the pulmonary vasculature. The present
study confirmed that hypoxia could not only induce HPASMC
proliferation, but could also suppress apoptosis in these cells, which
is in accordance with previous studies [18,25]. We, for the first
time, demonstrated that puerarin enhanced apoptosis (measured
by the TUNEL assay) in hypoxic HPASMCs in vitro through a
mechanism that involved the mitochondria-dependent pathway.
Hypoxic HPASMCs had a significantly increased Dym, which
contributed to the decrease of the mitochondrial permeability,
further suppressing apoptosis and increasing HPASMCs viability.
In addition, leakage of cytochrome c release to the cytosol was
suppressed in hypoxic HPASMCs. Furthermore, caspase-9 activity
was attenuated in hypoxic HPASMCs. Thus, we conclude that
mitochondria-dependent apoptosis is suppressed in hypoxic
HPASMCs. In contrast, puerarin depolarized HPASMC mito-
chondria and promoted the PT, the release of cytochrome c, and
the activation of caspase-9. These results show that the
mitochondria-dependent pathway is involved in puerarin-induced
apoptosis.
The pro-apoptotic protein Bax can translocate to the outer
membrane of mitochondria, change mitochondrial membrane
permeability, and promote the loss of Dym and cytochrome c
release [26,27]. On the other hand, Bcl-2, an anti-apoptotic
member, can be sequestered in mitochondria, inhibiting the
release of cytochrome c and preventing apoptosis. When
interacting with activated pro-apoptotic proteins, the anti-
apoptotic proteins lose their inhibiting activity, and apoptosis is
initiated [28]. In our study, we showed that the ratio of Bax to Bcl-
2 decreased in hypoxic HPASMCs and confirmed that apoptosis
was suppressed in hypoxic HPASMCs. Xu and colleagues [29]
found that 0.015–1.5 mM puerarin could significantly suppress
Bcl-2 expression increased by thrombin in aortic smooth muscle
cells. Additionally, Kang and colleagues [30] found that puerarin
increased Bax levels and the Bax/Bcl-xl ratio in umbilical artery
smooth muscle cells. In this study, at 50 or 100 mM, puerarin
increased the ratio of Bax to Bcl-2 in hypoxic HPASMCs, which
suggests that puerarin induces apoptosis in HPASMCs by
modulating Bcl-2 family proteins upstream of the mitochondrial
apoptotic pathway.
Our study alsodemonstrated that there wereno significant effects
on normal HPASMCs treated with puerarin at 50 mM for 24 h.
Previous studies [31,32] documented that upon administration of
puerarin to chronic hypoxic rats, the mean pulmonary arterial
pressure decreased markedly, but no significant change occurred in
the mean carotid pressure. Additionally, puerarin protects various
cell types from apoptosis [33–35], but induces apoptosis in some
hyperproliferative cells, such as tumor cells and aortic smooth
muscle cells stimulated by thrombin [22,23,29]. At present, we have
no clear explanation for this pattern, but it is tempting to
hypothesize that puerarin may target mitochondria only in
proliferating HPASMCs, minimizing possible toxicity to healthy
cells and tissues. However, further investigation is required.
In conclusion, our results show that puerarin can induce
apoptosis, which is inhibited in hypoxic HPASMCs, and the
mitochondria-dependent pathway is involved in puerarin-induced
apoptosis. The present study provides a new theoretical basis for
the use of puerarin in the management of hypoxic PH in the clinic.
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